Discover how Evelo’s EDP1815 may prevent the progression of COVID-19. Learn More

Our Science
Our Portfolio
Publications
About Us
Investors
Careers
Contact

Cancer Microbiome Play Evelo Raises $35M

BioCentury - November 4, 2015

Read the original article here

© Evelo Biosciences, Inc.
EVELO is a registered U.S. trademark of Evelo Biosciences, Inc.

Terms and Conditions of Use / Privacy Policy